Informasjon
Muskeldystrofi er betegnelser på tilstander hvor musklene ikke utvikler seg som de skal, og blir tynne og svake.
Beckers muskeldystrofi
Beckers muskeldystrofi er en sykdom som utvikles langsomt. Symptomene blir oftest tydelige når barnet er i 10-års alderen. Dystrofinmangel gir muskelsvakhet, og dette viser seg først i store muskelgrupper som lår og sete.
Sist oppdatert:
12. juli 2022
Dette dokumentet er basert på det profesjonelle dokumentet Beckers muskeldystrofi . Referanselisten for dette dokumentet vises nedenfor
Referanser
- Munot P. Muscular dystrophies. BMJ Best Practice. Last updated 23 Mar 2021. bestpractice.bmj.com
- Rasmussen M, Lien E, Mork M, Wallace S. Nevromuskulære sykdommer. Generell veileder i pediatri. Sist revidert 2020. www.helsebiblioteket.no
- Frambu kompetansesenter for sjeldne diagnoser. Medisinsk beskrivelse av Beckers muskeldystrofi. Siden besøkt 12.07.2022. frambu.no
- Romitti P, Puzhankara S, Mathews K, et al. Prevalence of Duchenne/Becker muscular dystrophy among males aged 5-24 years four states, 2007. JAMA 2009; 302: 2539-46. Journal of the American Medical Association
- Aartsma-Rus A, Van Deutekom JC, Fokkema IF, et al. Entries in the Leiden Duchenne muscular dystrophy mutation database: an overview of mutation types and paradoxical cases that confirm the reading-frame rule. Muscle Nerve 2006; 34: 135. pmid:16770791 PubMed
- Lager C, Kroksmark Ak. Pain in adolescents with spinal muscular atrophy and Duchenne and Becker muscular dystrophy. Eur J Paediatr Neurol 2015; 19: 537-46. pmid:25978940 PubMed
- Kang PB, Morrison L, Iannaccone ST, et al. Evidence-based guideline summary: evaluation, diagnosis, and management of congenital muscular dystrophy: Report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Issues Review Panel of the American Association of Neuromuscular & Electrodiagnostic Medicine. Neurology 2015; 84: 1369-78. pmid:25825463 PubMed
- Andersen G, Prahm KP, Dahlqvist JR, et al. Aerobic training and postexercise protein in facioscapulohumeral muscular dystrophi. Neurology 2015; 85: 396-403. doi:http://dx.doi.org/10.1212/WNL.0000000000001808.
- Darras BT. Duchenne and Becker muscular dystrophy: Management and prognosis. UpToDate, last updated Jul 01, 2022. UpToDate
- Duboc D, Meune C, Pierre B, et al. Perindopril preventive treatment on mortality in Duchenne muscular dystrophy: 10 years' follow-up. Am Heart J 2007; 154: 596-602. PMID: 17719312 PubMed
- Bourke JP, Bueser T, Quinlivan R. Interventions for preventing and treating cardiac complications in Duchenne and Becker muscular dystrophy and X‐linked dilated cardiomyopathy. Cochrane Database of Systematic Reviews 2018, Issue 10. Art. No.: CD009068. DOI: 10.1002/14651858.CD009068.pub3 DOI
- Kley RA, Tarnopolsky MA, Vorgerd M. Creatine for treating muscle disorders. Cochrane Database of Systematic Reviews 2013, Issue 6. Art. No.: CD004760. DOI: 10.1002/14651858.CD004760.pub4 DOI
- Welch EM, Barton ER, Zhuo J, et al. PTC124 targets genetic disorders caused by nonsense mutations. Nature 2007; 447: 87. pmid:17450125 PubMed